Pfizer $1.9 Bil. Vicuron Acquisition Culminates Antibiotic Research Deal
Pfizer's $1.9 bil. purchase of Vicuron marks the culmination of a six-year collaboration between the pharma giant and the biotech company to develop new antibiotic candidates
Pfizer's $1.9 bil. purchase of Vicuron marks the culmination of a six-year collaboration between the pharma giant and the biotech company to develop new antibiotic candidates